Hamilton Lane Advisors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Hamilton Lane Advisors’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,636	Closed	-$264K	–	74
2016 Q3	$264K	Sell	12,636 -14,944	-54%	-$172K	0.13%	54
2016 Q2	$277K	Hold	27,580	–	–	0.13%	54
2016 Q1	$183K	Hold	27,580	–	–	0.09%	52
2015 Q4	$499K	Sell	27,580 -143,355	-84%	-$1.97M	0.22%	42
2015 Q3	$1.88M	Buy	+170,935	New	+$1.82M	0.93%	24
2015 Q2	–	Sell	-13,537	Closed	-$159K	–	78
2015 Q1	$159K	Buy	+13,537	New	+$183K	0.07%	48

Hamilton Lane Advisors's VTAE Position: Q4 2016 in Review

Hamilton Lane Advisors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 12,636 shares — an estimated $264K sold.

Hamilton Lane Advisors first reported a position in VTAE in Q1 2015 and held it in 6 quarters. The position peaked at $1.88M in Q3 2015. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Hamilton Lane Advisors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Hamilton Lane Advisors sold 12,636 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $264K.
Hamilton Lane Advisors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 6 quarters.
Hamilton Lane Advisors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.88M in Q3 2015.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Hamilton Lane Advisors's 13F filing for Q4 2016, filed 26 Jan 2017.